IL22 and neoplasm: Polarization of Th17 and related cytokines including 1L-17A, IL-17F, IL-21, IL-22, TNF-α, and IL-6, in CRCs is associated with tumour promoting inflammation, immunosuppression, induction of pro-angiogenic factors, and poor patient outcome [115,116].